{
  "pmid": "29907525",
  "uid": "29907525",
  "title": "Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells.",
  "abstract": "The local regulation of type 2 immunity relies on dialog between the epithelium and the innate and adaptive immune cells. Here we found that alarmin-induced expression of the co-stimulatory molecule OX40L on group 2 innate lymphoid cells (ILC2s) provided tissue-restricted T cell co-stimulation that was indispensable for Th2 and regulatory T (Treg) cell responses in the lung and adipose tissue. Interleukin (IL)-33 administration resulted in organ-specific surface expression of OX40L on ILC2s and the concomitant expansion of Th2 and Treg cells, which was abolished upon deletion of OX40L on ILC2s (Il7ra[Cre/+]Tnfsf4[fl/fl] mice). Moreover, Il7ra[Cre/+]Tnfsf4[fl/fl] mice failed to mount effective Th2 and Treg cell responses and corresponding adaptive type 2 pulmonary inflammation arising from Nippostrongylus brasiliensis infection or allergen exposure. Thus, the increased expression of OX40L in response to IL-33 acts as a licensing signal in the orchestration of tissue-specific adaptive type 2 immunity, without which this response fails to establish.",
  "authors": [
    {
      "last_name": "Halim",
      "fore_name": "Timotheus Y F",
      "initials": "TYF",
      "name": "Timotheus Y F Halim",
      "affiliations": [
        "MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK; University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK. Electronic address: tim.halim@cruk.cam.ac.uk."
      ]
    },
    {
      "last_name": "Rana",
      "fore_name": "Batika M J",
      "initials": "BMJ",
      "name": "Batika M J Rana",
      "affiliations": [
        "MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK."
      ]
    },
    {
      "last_name": "Walker",
      "fore_name": "Jennifer A",
      "initials": "JA",
      "name": "Jennifer A Walker",
      "affiliations": [
        "MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK."
      ]
    },
    {
      "last_name": "Kerscher",
      "fore_name": "Bernhard",
      "initials": "B",
      "name": "Bernhard Kerscher",
      "affiliations": [
        "MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK."
      ]
    },
    {
      "last_name": "Knolle",
      "fore_name": "Martin D",
      "initials": "MD",
      "name": "Martin D Knolle",
      "affiliations": [
        "MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK; Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK."
      ]
    },
    {
      "last_name": "Jolin",
      "fore_name": "Helen E",
      "initials": "HE",
      "name": "Helen E Jolin",
      "affiliations": [
        "MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK."
      ]
    },
    {
      "last_name": "Serrao",
      "fore_name": "Eva M",
      "initials": "EM",
      "name": "Eva M Serrao",
      "affiliations": [
        "University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK."
      ]
    },
    {
      "last_name": "Haim-Vilmovsky",
      "fore_name": "Liora",
      "initials": "L",
      "name": "Liora Haim-Vilmovsky",
      "affiliations": [
        "Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK."
      ]
    },
    {
      "last_name": "Teichmann",
      "fore_name": "Sarah A",
      "initials": "SA",
      "name": "Sarah A Teichmann",
      "affiliations": [
        "Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK."
      ]
    },
    {
      "last_name": "Rodewald",
      "fore_name": "Hans-Reimer",
      "initials": "HR",
      "name": "Hans-Reimer Rodewald",
      "affiliations": [
        "Division of Cellular Immunology, German Cancer Research Center, Heidelberg 69120, Germany."
      ]
    },
    {
      "last_name": "Botto",
      "fore_name": "Marina",
      "initials": "M",
      "name": "Marina Botto",
      "affiliations": [
        "Imperial College London, Department of Medicine, London, UK."
      ]
    },
    {
      "last_name": "Vyse",
      "fore_name": "Timothy J",
      "initials": "TJ",
      "name": "Timothy J Vyse",
      "affiliations": [
        "King's College London, Department of Medical and Molecular Genetics, London, UK."
      ]
    },
    {
      "last_name": "Fallon",
      "fore_name": "Padraic G",
      "initials": "PG",
      "name": "Padraic G Fallon",
      "affiliations": [
        "Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland."
      ]
    },
    {
      "last_name": "Li",
      "fore_name": "Zhi",
      "initials": "Z",
      "name": "Zhi Li",
      "affiliations": [
        "University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham B15 2TT, UK."
      ]
    },
    {
      "last_name": "Withers",
      "fore_name": "David R",
      "initials": "DR",
      "name": "David R Withers",
      "affiliations": [
        "University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham B15 2TT, UK."
      ]
    },
    {
      "last_name": "McKenzie",
      "fore_name": "Andrew N J",
      "initials": "ANJ",
      "name": "Andrew N J McKenzie",
      "affiliations": [
        "MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK. Electronic address: anm@mrc-lmb.cam.ac.uk."
      ]
    }
  ],
  "journal": {
    "title": "Immunity",
    "iso_abbreviation": "Immunity",
    "issn": "1097-4180",
    "issn_type": "Electronic",
    "volume": "48",
    "issue": "6",
    "pub_year": "2018",
    "pub_month": "Jun",
    "pub_day": "19"
  },
  "start_page": "1195",
  "end_page": "1207.e6",
  "pages": "1195-1207.e6",
  "language": "eng",
  "publication_types": [
    "Journal Article"
  ],
  "keywords": [
    "Adaptive Immunity",
    "Animals",
    "Cell Differentiation",
    "Immunity, Innate",
    "Interleukin-33",
    "Lymphocyte Activation",
    "Lymphocytes",
    "Membrane Glycoproteins",
    "Mice",
    "OX40 Ligand",
    "T-Lymphocytes, Regulatory",
    "Th2 Cells",
    "Tumor Necrosis Factors"
  ],
  "article_ids": {
    "pubmed": "29907525",
    "pmc": "PMC6015114",
    "doi": "10.1016/j.immuni.2018.05.003",
    "pii": "S1074-7613(18)30239-5"
  },
  "doi": "10.1016/j.immuni.2018.05.003",
  "pmc_id": "PMC6015114",
  "dates": {
    "completed": "2019-02-08",
    "revised": "2025-05-30"
  },
  "chemicals": [
    "Il33 protein, mouse",
    "Interleukin-33",
    "Membrane Glycoproteins",
    "OX40 Ligand",
    "Tnfsf4 protein, mouse",
    "Tumor Necrosis Factors"
  ],
  "grants": [
    {
      "grant_id": "110199/Z/15/Z",
      "agency": "Wellcome Trust",
      "country": "United Kingdom"
    },
    {
      "grant_id": "204622/Z/16/Z",
      "agency": "Wellcome Trust",
      "country": "United Kingdom"
    },
    {
      "grant_id": "24995",
      "agency": "Cancer Research UK",
      "country": "United Kingdom"
    },
    {
      "grant_id": "MC_U105178805",
      "agency": "Medical Research Council",
      "country": "United Kingdom"
    }
  ],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:05:00.656448",
    "pmid": "29907525"
  }
}